Chapter 4.2. Community-Acquired Pneumonia

  1. Peter G. Gibson1,
  2. Michael Abramson2,
  3. Richard Wood-Baker3,
  4. Jimmy Volmink4,
  5. Michael Hensley5 and
  6. Ulrich Costabel6
  1. Jihendra N Pande,
  2. Juhi Dhar and
  3. G Sowmya

Published Online: 25 OCT 2007

DOI: 10.1002/9780470987377.ch25

Evidence-based Respiratory Medicine

Evidence-based Respiratory Medicine

How to Cite

Pande, J. N., Dhar, J. and Sowmya, G. (2005) Community-Acquired Pneumonia, in Evidence-based Respiratory Medicine (eds P. G. Gibson, M. Abramson, R. Wood-Baker, J. Volmink, M. Hensley and U. Costabel), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470987377.ch25

Editor Information

  1. 1

    John Hunter Hospital, Newcastle, New South Wales, Australia

  2. 2

    Monash University, Central & Eastern Clinical School, The Alfred, Melbourne, Victoria, Australia

  3. 3

    University of Tasmania, Hobart, Tasmania, Australia

  4. 4

    University of Cape Town, Cape Town, South Africa

  5. 5

    University of Newcastle, Newcastle, New South Wales, Australia

  6. 6

    Ruhrlandklinik, Essen, Germany

Publication History

  1. Published Online: 25 OCT 2007
  2. Published Print: 22 NOV 2005

ISBN Information

Print ISBN: 9780727916051

Online ISBN: 9780470987377

SEARCH

Keywords:

  • community-acquired pneumonia;
  • industrialized countries;
  • risk stratification;
  • antibiotic therapy;
  • vaccination

Summary

This chapter contains sections titled:

  • Introduction

  • Definition of CAP

  • Diagnostic evaluation

  • Risk stratification

  • Use of risk stratification for management of patients with CAP

  • Antibiotic therapy

  • Vaccination for preventing CAP

  • Conclusion

  • Search strategy